XP-21510

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameXP-21510
Drug Alias Nametranexamic acid prodrug (Xenoport/Xanodyne)XP-27BXP-21510
ClassificationSmall molecules
Mechanisms of ActionPlasminogen inhibitorsBlood coagulation stimulants
TargetsPlasminogen
Therapy Area/IndicationsMenorrhagia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenoport Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMenorrhagia

Other Information

ATC CodeN/A
Related LinksN/A